Effects of Skeletally Anchored Maxillary Expander Via Two Approaches of Microosteoperforations

Posterior Crossbite Clinical Trial

Official title:

Dento-skeletal Effects of Skeletally Anchored Maxillary Expander Assisted With Two Approaches of Microosteoperforations

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05433038
• Other study ID #: 798/1901
• Status: Active, not recruiting
• Phase: N/A
• Start date: May 20, 2022
• Est. completion date: November 1, 2024

Study information

• Verified date: June 2022
• Source: Al-Azhar University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

study will be directed to evaluate two approaches of microosteoperforations during skeletally anchored maxillary expansion

Description:

Dento-skeletal effects of skeletally anchored maxillary expander assisted with two approaches of microosteoperforations.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 20
• Est. completion date: November 1, 2024
• Est. primary completion date: April 20, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 22 Years

Eligibility

Inclusion Criteria:

• All patients should satisfy the following criteria:-

1. An age range from 18-22.

2. Transverse maxillary deficiency.

3. Crossbite (unilateral or bilateral)

4. No previous orthodontic treatment.

5. Good oral and general health.

6. No systemic disease/ medication that could interfere with OTM.

Exclusion Criteria:

1. History of systemic and medical illness.

2. History of extraction of permanent teeth.

3. Previos orthodontic treatment.

4. Poor oral hygiene or periodontally compromised patient.

5. Patient with craniofacial anomaly or previous history of trauma,bruxism or parafunctions.

Related Conditions & MeSH terms

• Malocclusion
• Posterior Crossbite

Intervention

Device:
• skeletally anchored maxillary expander
used from day one and activated two times per day for two weeks

Locations

Country	Name	City	State
Egypt	Al-Azhar univesity	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Al-Azhar University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	skeletally transverse measurement	using cone beam computed tomography	from start of treatment until study completion an average of 1 year
Primary	dentolinear measurement	using cone beam computed tomography	from start of treatment until study completion an average of 1 year
Primary	dentoangular measurement	using cone beam computed tomography	from start of treatment until study completion an average of 1 year